We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Learn more
Cookie Preferences
Manage your cookie preferences. You can enable or disable different types of cookies below.
Join the list! Get updates on new episodes!
Stay Connected with the podcast! Join our mailing list and get the latest updates, helpful resources, and patient education directly to your inbox.
Where informed patients make confident treatment decisions.
Here's the episode summary for Episode 120: For most thyroid patients, an indeterminate biopsy result with a 50% malignancy risk means one thing: surgery. Chelsie Paulson refused to accept that. Chelsie had two solid thyroid nodules — one on each lobe — when her Afirma molecular testing came back with a 50% risk of malignancy and a suspicion for follicular thyroid cancer. Four ENTs told her the same thing: the protocol is clear, remove the thyroid. Two nights before her scheduled thyroidectomy, at 2 a.m., she sent an email to Dr. Emad Kandil at Tulane University. She didn't expect much. Instead, Dr. Kandil called her personally the next morning and told her to cancel her surgery. She got on a plane that day. Chelsie underwent Microwave Ablation on both nodules — combining MWA for the solid tissue with ethanol ablation for the fluid-filled spaces. She paired the procedure with an aggressive integrative health protocol to support her body's healing from the inside out. The result…